[The dynamics of the immunological indices during the treatment of recurrent erysipelas with the new immunostimulant bemitil].
Ratnikova LI · 1991 · Zhurnal mikrobiologii, epidemiologii i immunobiologii; 1991 Sep
Study findings
An adjunctive erysipelas report described changes in T-lymphocytes and immunoglobulins alongside improved response to multi-component standard care.
- Population and setting
- Human report; see summary and review scope
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Allocation, masking, group details and numerical outcomes require full-text appraisal; findings do not establish benefit in healthy users.
- Possible overlap between these 1991 erysipelas reports remains unresolved; do not count them as independent replication.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Ratnikova LI. [The dynamics of the immunological indices during the treatment of recurrent erysipelas with the new immunostimulant bemitil]. Zhurnal mikrobiologii, epidemiologii i immunobiologii; 1991 Sep 1991.
Molekul research summary: https://molekul.io/research/bemitil-extra-1759524. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry